I-4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory
Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
Igama leKhemikhali: 4-Aminopyridine
CAS: 504-24-5
Igama leMchiza | 4-Aminopyridine |
Izithethantonye | 4-AP;I-4-Pyridinamine;iFampridine;I-Dalfampridine;p-Aminopyridine;γ-Aminopyridine |
Inombolo yeCAS | 504-24-5 |
Inombolo yeCAT | RF-PI539 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C5H6N2 |
Ubunzima beMolekyuli | 94.12 |
Ukunyibilika | Inyibilika emanzini, i-Ethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystalline oMhlophe okanye oMthubi kancinane |
Indlela yoVavanyo / yoHlahlelo | ≥99.5% (HPLC) |
Indawo yokunyibilika | 157.0 ~ 162.0℃ |
Amanzi (KF) | ≤0.50% |
Uthuthu lweSulfate | ≤0.20% |
2-Aminopyridine | ≤0.10% |
3-Aminopyridine | ≤0.10% |
Ukungcola ngokupheleleyo | ≤0.50% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | abaPhakathi bamayeza;API |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
I-4-Aminopyridine (i-CAS: 504-24-5) yenye yee-amine ezintathu ze-isomeri ze-pyridine, i-compound ecocekileyo kakhulu, eyokwenziwa, kunye ne-biologically esebenzayo, esetyenziswa ngokubanzi kwi-organic synthesis, i-synthesis ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Ingredient (API). ) ukuhlanganiswa.I-4-Aminopyridine (i-4-AP, i-Fampridine, i-Dalfampridine) isetyenziswe njengesixhobo sophando ekuboniseni i-subtypes ye-channel ye-potassium.Kwakhona isetyenziswe njengeziyobisi, ukulawula ezinye zeempawu ze-multiple sclerosis, kwaye ibonakaliswe ukuphuculwa kweempawu zokuhamba kubantu abadala abaneenguqu ezininzi zesifo.I-US Food and Drug Administration (FDA) ivume ikhompawundi ngoJanuwari 22, 2010. I-Fampridine iphinda ithengiswe e-United States yi-Acorda Therapeutics kunye ne-Fampyra kwi-European Union, eCanada, nase-Australia.